Young-Chul Park
Algemeen Directeur bij MOA LIFE PLUS CO. LTD.
Vermogen: 21 M $ op 30-04-2024
Profiel
Young-Chul Park is currently the CEO, Director & Head-Management at BL Pharmtech Corp.
and the Chief Executive Officer & Director at BL Corp.
(South Korea).
Previously, he held the position of Chief Executive Officer & Director at TCM Biosciences, Inc. Dr. Park holds a doctorate degree from Yonsei University and an undergraduate degree from Kyung Hee University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MOA LIFE PLUS CO. LTD.
22.13% | 16-04-2024 | 7 244 268 ( 22.13% ) | 21 M $ | 30-04-2024 |
BL PHARMTECH CORP.
0.18% | 18-03-2024 | 161 742 ( 0.18% ) | 57 811 $ | 30-04-2024 |
Actieve functies van Young-Chul Park
| Bedrijven | Functie | Begin |
|---|---|---|
| MOA LIFE PLUS CO. LTD. | Algemeen Directeur | - |
| BL PHARMTECH CORP. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Young-Chul Park
| Bedrijven | Functie | Einde |
|---|---|---|
TCM Biosciences, Inc.
 TCM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology TCM Biosciences, Inc. engages in the provision of electrical diagnostic services. Its products include human papillomavirus self collection kit, sample preparation equipment, respiratory disease diagnosis, glizigen, cosmeceuticals, and medical devices. The company was founded on August 3, 2009 and is headquartered in Seongnam-si, South Korea. | Algemeen Directeur | - |
Opleiding van Young-Chul Park
| Kyung Hee University | Undergraduate Degree |
| Yonsei University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| MOA LIFE PLUS CO. LTD. | Health Technology |
| BL PHARMTECH CORP. | Process Industries |
| Bedrijven in privébezit | 1 |
|---|---|
TCM Biosciences, Inc.
TCM Biosciences, Inc. Pharmaceuticals: MajorHealth Technology TCM Biosciences, Inc. engages in the provision of electrical diagnostic services. Its products include human papillomavirus self collection kit, sample preparation equipment, respiratory disease diagnosis, glizigen, cosmeceuticals, and medical devices. The company was founded on August 3, 2009 and is headquartered in Seongnam-si, South Korea. | Health Technology |
